Study participants and study setting
T2DM, chronic kidney disease
SICKLE CELL DISEASE
Eligibility criteria included aged 18 years or above, ability to participate in activities in a group setting, known to have T2DM, and not known to have chronic kidney disease or sickle cell disease.The study was conducted between January-May 2021, at two public primary facilities in Accra, Ghana. Potential participants were identified by searching electronic medical records of the study sites. Using attendance records, trained staff called all potential participants meeting eligibility criteria and invited them to participate. Participants, who expressed interest in the study, were given appointments for a screening visit at the study sites. Participants were recruited from 22Prior to any study procedures, all participants gave written informed consent in person. Participants received reimbursement for travel costs and time.